No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CG Oncology Amends Key Executive Employment Agreements
H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $75
Buy Rating for CG Oncology, Inc.: Strong Potential Amid Market Dynamics and Strategic Positioning
LifeSci Capital Maintains CG Oncology(CGON.US) With Buy Rating, Cuts Target Price to $83
LifeSci Capital Remains a Buy on CG Oncology, Inc. (CGON)
CG Oncology Shares Are Trading Higher After TD Cowen Initiated Coverage on the Stock With a Buy Rating.